Paul Nghiem

Professor

University of Washington

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Paul Nghiem is a faculty member at the University of Washington in the United States. His research primarily focuses on Merkel cell carcinoma, particularly the impacts of immunotherapy on patient outcomes, and the biological characteristics of the disease. Recent publications include studies on therapeutic strategies and patient management in advanced stages of the cancer, providing insights into biomarkers and the efficacy of various treatment approaches.

Articles (16)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (14)

Xinyi Fan

UNITED STATES

View details

Michi Shinohara

Associate Professor

University of Washington

UNITED STATES

View details

Lisa C Zaba

Stanford University School of Medicine

UNITED STATES

View details

Song Youn Park

Assistant Professor

University of Washington

UNITED STATES

View details

Tomoko Akaike

Assistant professor

University of Washington

UNITED STATES

View details

Kevin Chiu

Santa Clara University

UNITED STATES

View details

Sine Reker Hadrup

Technical University of Denmark

DENMARK

View details

Ata Moshiri

Assistant Professor

NYU School of Medicine

UNITED STATES

View details

Evan Hall

Assistant Professor

University of Washington

UNITED STATES

View details

Taofeek Owonikoko

Professor and Division Chief

University of Pittsburgh

UNITED STATES

View details

Richard K. Cheng

UNITED STATES

View details

Shailender Bhatia

Fred Hutchinson Cancer Research Center

UNITED STATES

View details

Kimberly Smythe

Fred Hutchinson Cancer Research Center

UNITED STATES

View details

Per thor Straten

Københavns Universitet

DENMARK

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Paul Nghiem

Research Interests

Explore related searches

Contact this professor

About

Articles (16)

Improved survival at the population level for patients with advanced Merkel cell carcinoma following availability of immunotherapy

Evolving Standards for Resected High-Risk CSCC: Integrating Insights from C-POST and KEYNOTE-630

Characterization of Immunosuppressive Myeloid Cells in Merkel Cell Carcinoma: Correlation with Resistance to PD-1 Pathway Blockade

Merkel cell carcinoma refractory to anti-PD(L)1: utility of adding ipilimumab for salvage therapy

Lack of Clinically Significant Relationships of Age or Body Mass Index with Merkel Cell Carcinoma Immunotherapy Outcomes

Biomarker Analyses Investigating Disease Biology and Associations with Outcomes in the JAVELIN Merkel 200 Trial of Avelumab in Metastatic Merkel Cell Carcinoma

Management and Prognosis of Cardiac Metastatic Merkel Cell Carcinoma: A Case–Control Study and Literature Review

Extended T-Cell Epitope Landscape in Merkel Cell Polyomavirus Large T and Small T Oncoproteins Identified Uniquely in Patients with Cancer

Real-world clinical outcomes with avelumab in patients with Merkel cell carcinoma treated in the USA: a multicenter chart review study

Assessment of hyperprogression versus the natural course of disease development with nivolumab with or without ipilimumab versus placebo in phase III, randomized, controlled trials

Cutaneous Merkel cell carcinoma (MCC): A report from the 16th Annual Meeting for Multicenter Merkel Interest Group - A supplementation to the new European guidelines 2022 on MCC

Germline cancer predisposition variants in a cohort of early-onset Merkel cell carcinoma patients

Recurrence and Mortality Risk of Merkel Cell Carcinoma by Cancer Stage and Time From Diagnosis

Response to "Mohs surgery for early-stage Merkel cell carcinoma (MCC) achieves local control better than wide local excision plus /- radiation therapy with no increase in MCC-specific death"

Scientific and clinical developments in Merkel cell carcinoma: A polyomavirus-driven, often-lethal skin cancer

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of nonmelanoma skin cancer

Collaborators (14)

Xinyi Fan

Michi Shinohara

Lisa C Zaba

Song Youn Park

Tomoko Akaike

Kevin Chiu

Sine Reker Hadrup

Ata Moshiri

Evan Hall

Taofeek Owonikoko

Richard K. Cheng

Shailender Bhatia

Kimberly Smythe

Per thor Straten

Make your next move.